Cost-effectiveness analysis of antiviral therapy in patients with advanced hepatitis B virus-related hepatocellular carcinoma treated with sorafenib
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cost-effectiveness analysis of antiviral therapy in patients with advanced hepatitis B virus-related hepatocellular carcinoma treated with sorafenib
Authors
Keywords
-
Journal
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
Volume 31, Issue 12, Pages 1978-1985
Publisher
Wiley
Online
2016-04-27
DOI
10.1111/jgh.13425
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cost-Effectiveness Analysis of Antiviral Therapies for Hepatitis B e Antigen-Positive Chronic Hepatitis B Patients in China
- (2015) Chi Zhang et al. CLINICAL DRUG INVESTIGATION
- Cost-effectiveness of sorafenib as a first-line treatment for advanced hepatocellular carcinoma
- (2015) Pengfei Zhang et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Antiviral therapy in the improvement of survival of patients with hepatitis B virus-related hepatocellular carcinoma treated with sorafenib
- (2015) Li Xu et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- A high baseline HBV load and antiviral therapy affect the survival of patients with advanced HBV-related HCC treated with sorafenib
- (2015) Yu Yang et al. LIVER INTERNATIONAL
- Management of hepatitis B virus infection during treatment for hepatitis B virus-related hepatocellular carcinoma
- (2015) Shoji Kubo WORLD JOURNAL OF GASTROENTEROLOGY
- Hepatitis B viral load affects prognosis of hepatocellular carcinoma
- (2014) Su Jong Yu WORLD JOURNAL OF GASTROENTEROLOGY
- Cost-effectiveness of sorafenib treatment in field practice for patients with hepatocellular carcinoma
- (2013) Calogero Cammà et al. HEPATOLOGY
- High viral load is associated with poor overall and recurrence-free survival of hepatitis B virus-related hepatocellular carcinoma after curative resection: A prospective cohort study
- (2012) T. Yang et al. EJSO
- Viral and host inflammation-related factors that can predict the prognosis of hepatocellular carcinoma
- (2012) Liping Chen et al. EUROPEAN JOURNAL OF CANCER
- Hepatitis B virus-related decompensated liver cirrhosis: Benefits of antiviral therapy
- (2012) Cheng-Yuan Peng et al. JOURNAL OF HEPATOLOGY
- Hepatocellular carcinoma
- (2012) Alejandro Forner et al. LANCET
- Prognostic indicators of survival in patients with compensated and decompensated cirrhosis
- (2012) Alexander Zipprich et al. LIVER INTERNATIONAL
- Morbidity and mortality following transarterial liver chemoembolization in patients with hepatocellular carcinoma and synthetic hepatic dysfunction
- (2012) Elisabeth R. Garwood et al. LIVER TRANSPLANTATION
- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Management of hepatocellular carcinoma: An update
- (2011) Jordi Bruix et al. HEPATOLOGY
- Liver cancer epidemic in China: Past, present and future
- (2010) Jian Guo Chen et al. SEMINARS IN CANCER BIOLOGY
- Cost-Effectiveness of Nucleoside Analog Therapy for Hepatitis B in China: A Markov Analysis
- (2010) Bin Wu et al. VALUE IN HEALTH
- Nucleotide Analogs for Patients with HBV-Related Hepatocellular Carcinoma Increase the Survival Rate through Improved Liver Function
- (2009) Masahiko Koda et al. INTERNAL MEDICINE
- Modeling the cost-effectiveness of different oral antiviral therapies in patients with chronic hepatitis B
- (2009) Maria Buti et al. JOURNAL OF HEPATOLOGY
- Economic evaluation of sunitinib malate in second-line treatment of metastatic renal cell carcinoma in Finland
- (2008) Timo Purmonen et al. CLINICAL THERAPEUTICS
- Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
- (2008) Ann-Lii Cheng et al. LANCET ONCOLOGY
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now